NorthWest Biotherapeutics Inc (NWBO)

[Gus1212]

I have a silly question:

For the sake of argument lets say that DCVAX extends life to 4 years
when the tumor would come back and be detected by another scan.

Can the patient then under go another tumor resection and receive a new Vaccine of DCVAX? Given that the tumor had a new signature this would be picked up by the process where the new DCVAX vaccine would be adjusted and have a very good chance of attacking the new tumor? (For another 4 years)

I realize that this would never be attempted in a trial because the trail needs events. Which is a lousy way of stating the obvious.


Things have slowed down so I thought that I would throw this out..